Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Urology Care, and Wound & Skin Care. It provides ostomy care products for intestinal dysfunction resulting from disease, accident, and congenital disorder. The company's ostomy care products include colostomy, ileostomy, and urostomy bags under the SenSura brand; and SenSura Mio, a colostomy product with elastic adhesive that fits individual body shapes, as well as ostomy accessories under the Brava brand. It also offers urology care products for people suffering from diseases and symptoms of the urinary system, pelvic floor prolapse, and the male reproductive system, such as urinary incontinence, kidney stones, enlarged prostate, and impotence. The company's disposable surgical devices include prostate catheters and stents used for urological and gynecological applications before, during, and after surgery under the Porgès brand; vaginal slings to restore continence; synthetic mesh products to treat weak pelvic floor; and penile implants for men. In addition, it provides continence care products, such as SpeediCath catheters that offer catherisation for both genders; Peristeen, an anal irrigation system for controlled emptying of the bowels; and Conveen Active urine bags. Further, the company offers wound care products, such as foam dressings under the Biatain brand and hydrocolloid dressing under the Comfeel brand, as well as skin care products, such as disinfectant liquids or creams used to protect and treat the skin and to clean wounds. Additionally, it offers Interdry, a textile placed in a skin fold to absorb moisture for treatment and prevention of skin fold problems, such as fungal infections, damaged skin, or odour nuisance. The company supplies its products to hospitals, institutions, wholesalers, and pharmacies; and directly to users. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:CLPBY
CUSIPN/A
Phone45-4911-1111
Debt
Debt-to-Equity Ratio0.02
Current Ratio0.95
Quick Ratio0.71
Price-To-Earnings
Trailing P/E Ratio37.74
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$2.31 billion
Price / Sales8.75
Cash Flow$0.3326 per share
Price / Cash30.64
Book Value$0.45 per share
Price / Book22.64
Profitability
EPS (Most Recent Fiscal Year)$0.27
Net Income$564.23 million
Net Margins23.55%
Return on Equity73.04%
Return on Assets31.16%
Miscellaneous
EmployeesN/A
Outstanding Shares1,980,000,000
Market Cap$20.07 billion
COLOPLAST A/S/ADR (OTCMKTS:CLPBY) Frequently Asked Questions
What is COLOPLAST A/S/ADR's stock symbol?
COLOPLAST A/S/ADR trades on the OTCMKTS under the ticker symbol "CLPBY."
When is COLOPLAST A/S/ADR's next earnings date?
Who are some of COLOPLAST A/S/ADR's key competitors?
Some companies that are related to COLOPLAST A/S/ADR include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Align Technology (ALGN), Zimmer Biomet (ZBH), Smith & Nephew (SNN), WILLIAM DEMANT/ADR (WILYY), Steris (STE), Inogen (INGN), MSA Safety (MSA), Avanos Medical (AVNS), Wright Medical Group (WMGI), Halyard Health (HYH), CONSORT Med PLC/S (CSRMY), Sientra (SIEN) and Invacare (IVC).
Who are COLOPLAST A/S/ADR's key executives?
COLOPLAST A/S/ADR's management team includes the folowing people:
- Mr. Lars Søren Rasmussen, Chief Exec. Officer and Pres (Age 59)
- Mr. Anders Lonning-Skovgaard, Exec. VP & CFO (Age 46)
- Mr. Allan Rasmussen, Exec. VP of Global Operations (Age 51)
- Mr. Kristian Villumsen, Exec. VP of Chronic Care (Age 48)
- Ellen Bjurgert, Director of Investor Relations
Has COLOPLAST A/S/ADR been receiving favorable news coverage?
Media headlines about CLPBY stock have been trending somewhat positive recently, according to Accern. The research group identifies negative and positive news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. COLOPLAST A/S/ADR earned a news impact score of 0.18 on Accern's scale. They also assigned media coverage about the company an impact score of 46.57 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term. View Recent Headlines for COLOPLAST A/S/ADR.
How do I buy shares of COLOPLAST A/S/ADR?
Shares of CLPBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is COLOPLAST A/S/ADR's stock price today?
One share of CLPBY stock can currently be purchased for approximately $10.19.
How big of a company is COLOPLAST A/S/ADR?
COLOPLAST A/S/ADR has a market capitalization of $20.07 billion and generates $2.31 billion in revenue each year. The company earns $564.23 million in net income (profit) each year or $0.27 on an earnings per share basis.
How can I contact COLOPLAST A/S/ADR?
COLOPLAST A/S/ADR's mailing address is HOLTEDAM 1-3, DK-3050 G7, . The company can be reached via phone at 45-4911-1111 or via email at [email protected]
MarketBeat Community Rating for COLOPLAST A/S/ADR (OTCMKTS CLPBY)
MarketBeat's community ratings are surveys of what our community members think about COLOPLAST A/S/ADR and other stocks. Vote "Outperform" if you believe CLPBY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLPBY will underperform the S&P 500 over the long term. You may vote once every thirty days.
